4000th Patient Treated With Innovative Tryton Medical, Inc. Side Branch Stent

DURHAM, N.C.--(BUSINESS WIRE)--Tryton Medical, Inc., the leading developer of stents designed to definitively treat bifurcation lesions, today announced that more than 4000 patients have been treated with the company’s Tryton™ Side Branch Stent in Europe, Russia and the Middle East.

Back to news